ArticlePharmaceuticals (Basel, Switzerland)2025

YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer.

Vicenç Ruiz de Porras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.